Insufficient scRNA-seq data for expression of ENTPD2 at tissue level.
Tissue | GTEx Coverage  | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 97% | 714.65 | 938 / 966 | 95% | 46.04 | 501 / 527 |
| prostate | 93% | 616.66 | 229 / 245 | 99% | 30.64 | 495 / 502 |
| stomach | 96% | 332.38 | 346 / 359 | 89% | 38.82 | 255 / 286 |
| brain | 96% | 676.74 | 2528 / 2642 | 81% | 21.82 | 573 / 705 |
| kidney | 93% | 545.46 | 83 / 89 | 82% | 20.25 | 743 / 901 |
| esophagus | 89% | 303.83 | 1281 / 1445 | 81% | 27.34 | 149 / 183 |
| breast | 74% | 624.64 | 340 / 459 | 88% | 21.78 | 981 / 1118 |
| pancreas | 47% | 96.33 | 155 / 328 | 89% | 26.73 | 158 / 178 |
| uterus | 69% | 224.95 | 118 / 170 | 60% | 13.58 | 276 / 459 |
| ovary | 19% | 39.68 | 35 / 180 | 87% | 23.50 | 372 / 430 |
| bladder | 52% | 123.57 | 11 / 21 | 51% | 14.61 | 255 / 504 |
| skin | 72% | 718.09 | 1305 / 1809 | 7% | 4.98 | 34 / 472 |
| heart | 67% | 189.83 | 573 / 861 | 0% | 0 | 0 / 0 |
| thymus | 23% | 43.96 | 150 / 653 | 39% | 9.54 | 236 / 605 |
| lung | 12% | 22.69 | 71 / 578 | 42% | 7.73 | 490 / 1155 |
| liver | 12% | 20.37 | 28 / 226 | 36% | 6.01 | 145 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 6.33 | 21 / 45 |
| adipose | 35% | 88.56 | 425 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 17% | 62.01 | 222 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 16% | 58.78 | 147 / 929 | 0% | 0 | 0 / 0 |
| muscle | 10% | 16.42 | 77 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 3% | 7.70 | 9 / 258 | 1% | 0.27 | 3 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 2.87 | 1 / 29 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.09 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0009134 | Biological process | nucleoside diphosphate catabolic process |
| GO_0009181 | Biological process | purine ribonucleoside diphosphate catabolic process |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0030168 | Biological process | platelet activation |
| GO_0005604 | Cellular component | basement membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0004382 | Molecular function | GDP phosphatase activity |
| GO_0045134 | Molecular function | UDP phosphatase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0017111 | Molecular function | ribonucleoside triphosphate phosphatase activity |
| Gene name | ENTPD2 |
| Protein name | Ectonucleoside triphosphate diphosphohydrolase 2 (NTPDase 2) (EC 3.6.1.-) (CD39 antigen-like 1) (Ecto-ATP diphosphohydrolase 2) (Ecto-ATPDase 2) (Ecto-ATPase 2) |
| Synonyms | CD39L1 |
| Description | FUNCTION: In the nervous system, could hydrolyze ATP and other nucleotides to regulate purinergic neurotransmission. Hydrolyzes ADP only to a marginal extent. The order of activity with different substrates is ATP > GTP > CTP = ITP > UTP >> ADP = UDP. |
| Accessions | Q9Y5L3 ENST00000355097.7 [Q9Y5L3-1] ENST00000312665.7 [Q9Y5L3-2] |
